Sophiris Bio (SPHS) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts SPHS Hot Sheet
Join SI Premium – FREE
Sophiris Bio (NASDAQ: SPHS) reported Q1 EPS of ($0.52), $0.02 worse than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Sophiris Bio (SPHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- West Coast Community Bancorp (WCCB) Tops Q3 EPS by 15c
- ’Bespoke opportunity’: RBC initiates Ermenegildo Zegna at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
